DocMorris AG (ZRSEF)
95.77
0.00 (0.00%)
USD |
OTCM |
Apr 23, 16:00
DocMorris Total Liabilities (Quarterly): 518.95M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 518.95M |
| June 30, 2023 | 574.31M |
| June 30, 2023 | 574.31M |
| December 31, 2022 | 807.50M |
| June 30, 2022 | 780.35M |
| June 30, 2022 | 780.35M |
| December 31, 2021 | 857.99M |
| June 30, 2021 | 852.66M |
| June 30, 2021 | 852.66M |
| December 31, 2020 | 854.71M |
| June 30, 2020 | 759.35M |
| Date | Value |
|---|---|
| June 30, 2020 | 759.35M |
| December 31, 2019 | 604.98M |
| June 30, 2019 | 378.96M |
| June 30, 2019 | 378.96M |
| December 31, 2018 | 287.36M |
| June 30, 2018 | 173.08M |
| June 30, 2018 | 173.08M |
| December 31, 2017 | 172.00M |
| June 30, 2017 | 179.21M |
| June 30, 2017 | 179.21M |
| December 31, 2016 | 155.00M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
378.96M
Minimum
Jun 2019
857.99M
Maximum
Dec 2021
689.03M
Average
759.35M
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| AC Immune SA | 26.40M |
| CRISPR Therapeutics AG | 346.77M |
| Addex Therapeutics Ltd | 4.163M |
| NLS Pharmaceutics Ltd | 6.557M |
| Molecular Partners AG | 26.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.032B |
| Shareholders Equity (Quarterly) | 512.57M |
| Debt to Equity Ratio | 0.7017 |
| Current Ratio | 1.629 |
| Net Debt Paydown Yield | 5.60% |